COVID-19 boosters promote immune response in additional blood cancer patients, and high drug costs lead cancer patients to not fill prescriptions.

by Kevin McLaughlin

Motherhood does not decrease chance of survival for women who have had breast cancer, and the FDA temporarily suspends ban on Juul e-cigarettes.

by Thomas Celona

Colorectal cancer screening less prevalent in the younger end of the recommended age group, and cancer patients targeted online with ads for unproven treatment.

by Eric Fitzsimmons

American Cancer Society reacts to Supreme Court decision, and research highlights the disproportionate burden of cancer mortality on Black people.

by Marci A. Landsmann

Clinical trials rebound after COVID-19 setbacks, and early treatment leads to significant reduction in anal cancer risk among people with HIV.

by Thomas Celona

Patients who lose weight through bariatric surgery have a lower cancer risk, and a HER2-targeted therapy gets striking results in HER2-low breast cancer patients.

by Kevin McLaughlin

Contrast dye shortage delays scans for cancer, and more public assistance linked to higher survival rates for Black cancer patients.

by Eric Fitzsimmons

A blood test could help determine who benefits from checkpoint inhibitors in lung cancer, and the FDA approves a drug combination for certain patients with acute myeloid leukemia.

by Marci A. Landsmann

Esophageal cancer increases in the middle-aged, and adolescent and young adult leukemia survivors face continued mortality risk after treatment ends.

by Eric Fitzsimmons

First child to receive CAR T-cell therapy celebrates 10 years cancer-free, and authorization denials delay treatment for patients with Medicare Advantage.

by Marci A. Landsmann